Franklin Resources’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Franklin Resources’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$98.6K	Buy	+55,996	New	+$226K	﹤0.01%	2937
2025 Q1	–	Sell	-106,748	Closed	-$323K	–	3083
2024 Q4	$323K	Buy	+106,748	New	+$350K	﹤0.01%	2479
2021 Q2	–	Sell	-327,197	Closed	-$14.2M	–	2080
2021 Q1	$14.2M	Hold	327,197	–	–	0.01%	911
2020 Q4	$17M	Buy	327,197 +152,112	+87%	+$6.86M	0.01%	851
2020 Q3	$5.72M	Buy	175,085 +35	+0%	+$1.22K	﹤0.01%	1024
2020 Q2	$7.38M	Buy	+175,050	New	+$6.71M	﹤0.01%	935

Other funds holding ZNTL

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Pfizer New York $164M AUM 53.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Franklin Resources's ZNTL Position: Q3 2026 in Review

Franklin Resources opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 55,996 shares worth $98.6K. The stake represents ﹤0.01% of the portfolio and ranks #2937 among its holdings. This is a return to the name: Franklin Resources previously reported a position in ZNTL as recently as Q4 2024.

Franklin Resources first reported a position in ZNTL in Q2 2020 and has held it in 6 quarters since. The position peaked at $17M in Q4 2020. 54 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

Franklin Resources held 55,996 shares of Zentalis Pharmaceuticals worth $98.6K as of Q3 2026.
Zentalis Pharmaceuticals was a new Franklin Resources position in Q3 2026.
Zentalis Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #2937 holding.
Franklin Resources first reported a position in Zentalis Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
Franklin Resources's Zentalis Pharmaceuticals position peaked at $17M in Q4 2020.
54 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.